Low‐protein and protein‐redistribution diets for Parkinson's disease patients with motor fluctuations: A systematic review
Identifieur interne : 000652 ( Main/Exploration ); précédent : 000651; suivant : 000653Low‐protein and protein‐redistribution diets for Parkinson's disease patients with motor fluctuations: A systematic review
Auteurs : Emanuele Cereda [Italie] ; Michela Barichella [Italie] ; Carlo Pedrolli [Italie] ; Gianni Pezzoli [Italie]Source :
- Movement Disorders [ 0885-3185 ] ; 2010-10-15.
English descriptors
- KwdEn :
Abstract
The American Academy of Neurology suggests advising the redistribution of daily protein meal content to every Parkinson's disease (PD) patient with motor fluctuations during levodopa treatment. However, no comprehensive evaluation of this complementary therapy has been performed. A systematic review of intervention studies investigating the neurologic outcome of low‐protein (<0.8 g/kg of ideal weight/day) and protein‐redistribution diets in patients with PD experiencing motor fluctuations during levodopa treatment. All studies (uncontrolled or randomized) investigating a low‐protein and/or a protein‐redistribution diet (LPD and PRD) and involving patients with PD with motor fluctuations were included, provided that sufficient information on dietary protein content and neurologic outcome measures was available. We identified 16 eligible studies, but they were markedly heterogeneous. There was not enough evidence to support the use of LPD. Response to PRD seemed very good. Acceptability appeared high upon introduction, but it seemed to progressively decrease over time. On average, PRD resulted in improved motor function, but also complications occurred. At the beginning, drop‐outs were due to levodopa side effects rather than unsatisfactory benefits. Long‐term adherence was more affected by changes in dietary habits than by diet‐related side effects. Efficacy and benefits appeared to be higher when the intervention was proposed to subjects in the early stages of PD. PRD can be safely advised to fluctuating patients with PD, but those in whom benefits override the possible inconveniences still need to be identified. The long‐term effects of PRD on nutritional status should be evaluated and true effectiveness in clinical practice should be reassessed, given the changes in levodopa formulations and the introduction of several adjuvants (levodopa degradation inhibitors and/or dopamine agonists). © 2010 Movement Disorder Society.
Url:
DOI: 10.1002/mds.23226
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Low‐protein and protein‐redistribution diets for Parkinson's disease patients with motor fluctuations: A systematic review</title><author><name sortKey="Cereda, Emanuele" sort="Cereda, Emanuele" uniqKey="Cereda E" first="Emanuele" last="Cereda">Emanuele Cereda</name></author><author><name sortKey="Barichella, Michela" sort="Barichella, Michela" uniqKey="Barichella M" first="Michela" last="Barichella">Michela Barichella</name></author><author><name sortKey="Pedrolli, Carlo" sort="Pedrolli, Carlo" uniqKey="Pedrolli C" first="Carlo" last="Pedrolli">Carlo Pedrolli</name></author><author><name sortKey="Pezzoli, Gianni" sort="Pezzoli, Gianni" uniqKey="Pezzoli G" first="Gianni" last="Pezzoli">Gianni Pezzoli</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A162D61265942C65BE5F0D525C28887B2B2CFBF5</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1002/mds.23226</idno><idno type="url">https://api.istex.fr/document/A162D61265942C65BE5F0D525C28887B2B2CFBF5/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000A88</idno><idno type="wicri:Area/Main/Curation">000951</idno><idno type="wicri:Area/Main/Exploration">000652</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Low‐protein and protein‐redistribution diets for Parkinson's disease patients with motor fluctuations: A systematic review</title><author><name sortKey="Cereda, Emanuele" sort="Cereda, Emanuele" uniqKey="Cereda E" first="Emanuele" last="Cereda">Emanuele Cereda</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, Parkinson Institute, Istituti Clinici di Perfezionamento, Milano</wicri:regionArea><wicri:noRegion>Milano</wicri:noRegion></affiliation></author><author><name sortKey="Barichella, Michela" sort="Barichella, Michela" uniqKey="Barichella M" first="Michela" last="Barichella">Michela Barichella</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, Parkinson Institute, Istituti Clinici di Perfezionamento, Milano</wicri:regionArea><wicri:noRegion>Milano</wicri:noRegion></affiliation></author><author><name sortKey="Pedrolli, Carlo" sort="Pedrolli, Carlo" uniqKey="Pedrolli C" first="Carlo" last="Pedrolli">Carlo Pedrolli</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Dietetic and Clinical Nutrition Unit, Trento Hospital, Trento</wicri:regionArea><wicri:noRegion>Trento</wicri:noRegion></affiliation></author><author><name sortKey="Pezzoli, Gianni" sort="Pezzoli, Gianni" uniqKey="Pezzoli G" first="Gianni" last="Pezzoli">Gianni Pezzoli</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, Parkinson Institute, Istituti Clinici di Perfezionamento, Milano</wicri:regionArea><wicri:noRegion>Milano</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2010-10-15">2010-10-15</date><biblScope unit="volume">25</biblScope><biblScope unit="issue">13</biblScope><biblScope unit="page" from="2021">2021</biblScope><biblScope unit="page" to="2034">2034</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">A162D61265942C65BE5F0D525C28887B2B2CFBF5</idno><idno type="DOI">10.1002/mds.23226</idno><idno type="ArticleID">MDS23226</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>levodopa</term><term>low‐protein diet</term><term>motor fluctuations</term><term>protein‐redistribution diet</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The American Academy of Neurology suggests advising the redistribution of daily protein meal content to every Parkinson's disease (PD) patient with motor fluctuations during levodopa treatment. However, no comprehensive evaluation of this complementary therapy has been performed. A systematic review of intervention studies investigating the neurologic outcome of low‐protein (<0.8 g/kg of ideal weight/day) and protein‐redistribution diets in patients with PD experiencing motor fluctuations during levodopa treatment. All studies (uncontrolled or randomized) investigating a low‐protein and/or a protein‐redistribution diet (LPD and PRD) and involving patients with PD with motor fluctuations were included, provided that sufficient information on dietary protein content and neurologic outcome measures was available. We identified 16 eligible studies, but they were markedly heterogeneous. There was not enough evidence to support the use of LPD. Response to PRD seemed very good. Acceptability appeared high upon introduction, but it seemed to progressively decrease over time. On average, PRD resulted in improved motor function, but also complications occurred. At the beginning, drop‐outs were due to levodopa side effects rather than unsatisfactory benefits. Long‐term adherence was more affected by changes in dietary habits than by diet‐related side effects. Efficacy and benefits appeared to be higher when the intervention was proposed to subjects in the early stages of PD. PRD can be safely advised to fluctuating patients with PD, but those in whom benefits override the possible inconveniences still need to be identified. The long‐term effects of PRD on nutritional status should be evaluated and true effectiveness in clinical practice should be reassessed, given the changes in levodopa formulations and the introduction of several adjuvants (levodopa degradation inhibitors and/or dopamine agonists). © 2010 Movement Disorder Society.</div></front></TEI><affiliations><list><country><li>Italie</li></country></list><tree><country name="Italie"><noRegion><name sortKey="Cereda, Emanuele" sort="Cereda, Emanuele" uniqKey="Cereda E" first="Emanuele" last="Cereda">Emanuele Cereda</name></noRegion><name sortKey="Barichella, Michela" sort="Barichella, Michela" uniqKey="Barichella M" first="Michela" last="Barichella">Michela Barichella</name><name sortKey="Pedrolli, Carlo" sort="Pedrolli, Carlo" uniqKey="Pedrolli C" first="Carlo" last="Pedrolli">Carlo Pedrolli</name><name sortKey="Pezzoli, Gianni" sort="Pezzoli, Gianni" uniqKey="Pezzoli G" first="Gianni" last="Pezzoli">Gianni Pezzoli</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000652 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000652 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:A162D61265942C65BE5F0D525C28887B2B2CFBF5
|texte= Low‐protein and protein‐redistribution diets for Parkinson's disease patients with motor fluctuations: A systematic review
}}
| This area was generated with Dilib version V0.6.23. |  |